Related references
Note: Only part of the references are listed.Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
A. -P. Magiorakos et al.
CLINICAL MICROBIOLOGY AND INFECTION (2012)
Current Definitions of Central Line-Associated Bloodstream Infection: Is the Emperor Wearing Clothes?
Daniel J. Sexton et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Multidrug Resistance among Gram-Negative Pathogens That Caused Healthcare-Associated Infections Reported to the National Healthcare Safety Network, 2006-2008
Alexander J. Kallen et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Health Care-Associated Invasive MRSA Infections, 2005-2008
Alexander J. Kallen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Annual Summary of Data Reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007
Alicia I. Hidron et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
First report of the emergence of CTX-M-Type extended-spectrum β-lactamases (ES-BLs) as the predominant ESBL isolated in a US health care Systemdel
James S. Lewis et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Anti-infective research and development - problems, challenges, and solutions
John S. Bradley et al.
LANCET INFECTIOUS DISEASES (2007)
Emergence of carbapenem-resistant Klebsiella species possessing the class A carbapenem-hydrolyzing KPC-2 and inhibitor-resistant TEM-30 β-lactamases in New York City
PA Bradford et al.
CLINICAL INFECTIOUS DISEASES (2004)
Share Paper
